Retreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia

Danielle M. Brander, Andrew W. Roberts, Thomas J. Kipps, Shuo Ma, Mary Ann Anderson, Michelle Boyer, Piers Blombery, Relja Popovic, Jordan Roser, Zhuangzhuang Liu, Brenda Chyla, John F. Seymour

Open source

DOI: 10.1002/hem3.70284
Published: 2025-12
Container: HemaSphere
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/hem3.70284,
  title = {Retreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia},
  author = {Danielle M. Brander and Andrew W. Roberts and Thomas J. Kipps and Shuo Ma and Mary Ann Anderson and Michelle Boyer and Piers Blombery and Relja Popovic and Jordan Roser and Zhuangzhuang Liu and Brenda Chyla and John F. Seymour},
  year = {2025},
  journal = {HemaSphere},
  doi = {10.1002/hem3.70284},
  url = {https://doi.org/10.1002/hem3.70284}
}

RIS

TY  - JOUR
TI  - Retreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia
AU  - Danielle M. Brander
AU  - Andrew W. Roberts
AU  - Thomas J. Kipps
AU  - Shuo Ma
AU  - Mary Ann Anderson
AU  - Michelle Boyer
AU  - Piers Blombery
AU  - Relja Popovic
AU  - Jordan Roser
AU  - Zhuangzhuang Liu
AU  - Brenda Chyla
AU  - John F. Seymour
PY  - 2025
JO  - HemaSphere
DO  - 10.1002/hem3.70284
UR  - https://doi.org/10.1002/hem3.70284
ER  -

APA

Brander, D. M., Roberts, A. W., Kipps, T. J., Ma, S., Anderson, M. A., Boyer, M., Blombery, P., Popovic, R., Roser, J., Liu, Z., Chyla, B., & Seymour, J. F. (2025). Retreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia. HemaSphere. https://doi.org/10.1002/hem3.70284

Source records

crossref · retrieved 2026-09-28T16:27:17.439Z